Cargando…
Clinical Outcomes After Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer: A Single Institutional Study
Introduction The standard of care for early-stage non-small cell lung cancer (NSCLC) is surgery. However, for medical inoperable patients stereotactic body radiation therapy (SBRT) is an alternative method. The aim of the study is to assess the overall survival (OS), progression-free survival (PFS)...
Autores principales: | Abdalmassih, Michael, Bucher, Oliver, Rathod, Shrinivas, Dubey, Arbind, Kim, Julian O, Ahmed, Naseer, Leylek, Ahmet, Chowdhury, Amitava, Bashir, Bashir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719484/ https://www.ncbi.nlm.nih.gov/pubmed/33304707 http://dx.doi.org/10.7759/cureus.11886 |
Ejemplares similares
-
Clinical Characteristics and Prognosis of Primary Tracheal Cancer: A Single Institution Experience
por: Koul, Rashmi, et al.
Publicado: (2018) -
Bracing for impact with new 4R’s in the COVID-19 pandemic – A provincial thoracic radiation oncology consensus()
por: Rathod, Shrinivas, et al.
Publicado: (2020) -
Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
por: AduQuaye, Marina, et al.
Publicado: (2022) -
A Call for a Radiation Oncology Model Based on New 4R’s During the COVID-19 Pandemic
por: Rathod, Shrinivas, et al.
Publicado: (2020) -
31: Single Fraction Peripheral Lung SBRT During the Global COVID-19 Pandemic at a Cancercare Manitoba: An Analysis of Technical Feasibility and Clinical Safety
por: Alfaifi, Salem, et al.
Publicado: (2022)